These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22221847)

  • 41. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
    Nichols WL; Hultin MB; James AH; Manco-Johnson MJ; Montgomery RR; Ortel TL; Rick ME; Sadler JE; Weinstein M; Yawn BP
    Haemophilia; 2008 Mar; 14(2):171-232. PubMed ID: 18315614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory identification of von Willebrand disease: technical and scientific perspectives.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):456-71. PubMed ID: 16862518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type 1 von Willebrand disease: application of emerging data to clinical practice.
    Collins PW; Cumming AM; Goodeve AC; Lillicrap D
    Haemophilia; 2008 Jul; 14(4):685-96. PubMed ID: 18510569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U; Drewke E; Mainusch K; Schneppenheim R
    Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
    De Meyer SF; Vandeputte N; Pareyn I; Petrus I; Lenting PJ; Chuah MK; VandenDriessche T; Deckmyn H; Vanhoorelbeke K
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1621-6. PubMed ID: 18556568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
    Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
    Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquired von Willebrand syndrome: features and management.
    Mohri H
    Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
    Kurth AA; Ludwig G; Scharrer I
    Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Von Willebrand disease: pathogenesis and management.
    Rodeghiero F
    Thromb Res; 2013 Jan; 131 Suppl 1():S47-50. PubMed ID: 23452742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Von Willebrand's disease.
    Ewenstein BM
    Annu Rev Med; 1997; 48():525-42. PubMed ID: 9046981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.
    Brehm MA; Huck V; Aponte-Santamaría C; Obser T; Grässle S; Oyen F; Budde U; Schneppenheim S; Baldauf C; Gräter F; Schneider SW; Schneppenheim R
    Thromb Haemost; 2014 Jul; 112(1):96-108. PubMed ID: 24598842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemistry and genetics of von Willebrand factor.
    Sadler JE
    Annu Rev Biochem; 1998; 67():395-424. PubMed ID: 9759493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimizing treatment of von Willebrand disease by using phenotypic and molecular data.
    Rodeghiero F; Castaman G; Tosetto A
    Hematology Am Soc Hematol Educ Program; 2009; ():113-23. PubMed ID: 20008189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.
    Lillicrap D
    Hematology Am Soc Hematol Educ Program; 2013; 2013():254-60. PubMed ID: 24319188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.
    Lillicrap D
    Blood; 2013 Nov; 122(23):3735-40. PubMed ID: 24065240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.